Evidence map›Paper›PMID 30241247›Full record

ReviewJournal of global oncology2018

Cancer Supportive and Survivorship Care in Singapore: Current Challenges and Future Outlook.

Kiley Wei-Jen Loh, Terence Ng, Su Pin Choo, Hay Mar Saw, Rathi Mahendran, Celia Tan, Gail Chia Yang Chang, Yew Jin Ong, Alethea Chung Pheng Yee, Alexandre Chan and 1 more

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04014309 (Supportive and Survivorship Care Program for Cancer Patients), which is not on this map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04014309 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Supportive and Survivorship Care Program for Cancer Patients: a Cluster Randomized Controlled Pilot Study Among Breast and Gynaecological Cancer Patients

TypeinterventionalSponsorNational University of SingaporeRan2019 to 2021Enrolled226ConditionsSurvivorship, Breast Cancer, Gynecologic CancerArmsSupportive and survivorship care program, Usual care
3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Observational
  13. Barriers and facilitators to exercise among adult cancer survivors in Singapore.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The haematopoietic stem cell transplant survivors' sense of coherence about their experiences: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kiley Wei-Jen LohWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Terence NgWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Su Pin ChooWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Hay Mar SawWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Rathi MahendranWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Celia TanWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Gail Chia Yang ChangWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Yew Jin OngWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Alethea Chung Pheng YeeWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Alexandre ChanWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.
Khee Chee SooWei-Jen Kiley Loh, Terence Ng, Su Pin Choo, Alethea Chung Pheng Yee, Alexandre Chan, and Khee Chee Soo, National Cancer Centre Singapore; Hay Mar Saw, Singapore General Hospital; Rathi Mahendran, National University Hospital; Celia Tan, Allied Health, Singhealth Services; Gail Chia Yang Chang, KK Women's and Children's Hospital; Yew Jin Ong, Singapore Cancer Society; and Alexandre Chan, National University of Singapore (NUS) and Duke-NUS Graduate Medical School, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite being a relatively young nation, Singapore has established itself as a leading multifaceted medical hub, both regionally and globally. Although Singapore continues to pursue excellence in oncology care, cancer supportive care and survivorship care remain in the infancy stage. In an effort to advance this important aspect of oncology care in Singapore, the first cancer supportive and survivorship care forum was held in December 2016, involving 74 oncology practitioners. The primary goals of this forum were to raise awareness of the importance of cancer supportive and survivorship care and to provide a platform for oncology practitioners of diverse backgrounds to converge and address the challenges associated with the delivery of cancer supportive and survivorship care in Singapore. Key challenges identified during this forum included, but were not limited to, care fragmentation in an oncologist-centric model of care, poor integration of allied health and rehabilitation services, passive engagement of community partners, lack of specialized skill sets and knowledge in supportive and survivorship care, and patient-related barriers such as poor health literacy. The survivorship care model commonly used in Singapore places an imbalanced emphasis on surveillance for cancer recurrence and second primary cancers, with little attention given to the supportive and survivorship needs of the survivors. In summary, these challenges set the stage for the development and use of a more survivor-centric model, one that focuses not only on cancer surveillance, but also on the broad and unique physical and psychosocial needs of survivors of cancer in Singapore.

Indexed as

Cancer SurvivorsPalliative CareSurvivorshipDelivery of Health CareHumansNeoplasmsSingapore

Identifiers

PMID30241247
PMCPMC6223422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.